Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.
Mandarano, Alexandra H, Maya, Jessica, Giloteaux, Ludovic et al. · The Journal of clinical investigation · 2020 · DOI
Quick Summary
This study looked at how immune cells (T cells) work differently in people with ME/CFS compared to healthy people. Researchers found that T cells from ME/CFS patients use energy less efficiently—they have trouble both producing energy at rest and responding when activated. These metabolic problems in immune cells may help explain why ME/CFS patients experience severe fatigue and other symptoms.
Why It Matters
Understanding T cell metabolic dysfunction provides a potential biological mechanism for ME/CFS symptoms and could guide development of targeted therapeutic interventions. This work strengthens the scientific basis for recognizing ME/CFS as an immune-mediated disease with measurable cellular abnormalities, validating patient experiences of fatigue and post-exertional malaise.
Observed Findings
CD8+ T cells from ME/CFS patients had reduced mitochondrial membrane potential compared to healthy controls.
Both CD4+ and CD8+ T cells showed reduced glycolysis at rest in ME/CFS patients.
CD8+ T cells from ME/CFS patients exhibited reduced glycolysis following activation.
ME/CFS patients demonstrated different patterns of correlation between T cell metabolic measures and plasma cytokine levels compared to healthy controls.
Inferred Conclusions
T cell metabolism is impaired in ME/CFS patients in ways consistent with ongoing immune dysfunction.
The metabolic abnormalities may contribute to the mechanism underlying severe fatigue and post-exertional malaise.
Disrupted relationships between cellular metabolism and circulating cytokines suggest systemic immune dysregulation in ME/CFS.
Remaining Questions
Are the observed metabolic abnormalities primary drivers of ME/CFS symptoms or secondary consequences of disease pathology?
Do these T cell metabolic changes persist over time or fluctuate with disease activity?
Can correcting T cell metabolism reduce symptoms and improve patient outcomes?
What This Study Does Not Prove
This study identifies metabolic abnormalities but does not prove they cause ME/CFS symptoms or are specific to this disease. It cannot establish whether T cell dysfunction is a primary cause or a consequence of disease processes. The correlation between metabolism and cytokines does not establish causation, and findings require validation in larger, prospective studies.